PDF printable version of New treatments for a healthier future from research innovation (PDF 287 KB)
23 June 2017
A $2.2 million injection from the Turnbull Government’s Medical Research Future Fund (MRFF) is set to accelerate the development of new patient treatments by Sydney Health Partners.
Announcing the funding today, Aged Care and Indigenous Health Minister Ken Wyatt said it would help deliver better health care for Australians.
“This is about translating research into results, strengthening the life-changing and life-saving links between science and patients,” the Minister said.
The funding is part of $10 million grant from the first disbursements from the MRFF.
A total of $65.9 million from the fund is being provided in 2016-17 to researchers across eight strategic investment programs.
Minister Wyatt said Sydney Health Partners, one of Australia’s first four Advanced Health Research and Translation Centres, was an excellent model for medical innovation.
“Their work brings together the Sydney, Northern Sydney and Western Sydney Local Health Districts, the Sydney Children’s Hospitals Network, the University of Sydney, and nine affiliated independent medical research institutes,” he said.
“This funding will accelerate projects to help people access new and better treatments for conditions such as cancer, dementia and heart disease.
“It will also support improved indigenous health, increased patient participation and help address treatment gaps in the health system.”
Sydney Health Partners recently awarded funding to three collaborative ventures:
- The Acute Lower Back Pain project
- The ClinTrial Refer Project
- The Turning Point Project
“Through the MRFF, we are securing Australia’s place as a health and medical research powerhouse, nurturing and building on the enormous talent we have in our medical community.
“The Turnbull Government is committed to medical innovation and is making a bigger contribution to this field than ever before.”
Media contact: Nick Way, Media Adviser 0419 835 449